Which tb is not curable

Isoniazid, Rifampicin and Pyrazinamide can all come in the same tablet, called Rifater. After two months of treatment you may change to two antibiotics, Rifampicin and Isoniazid.

These can come in a single tablet, called Rifinah. With any medication, it is possible to have side effects. Most are nothing to worry about and will go away. Your TB nurse or doctor should advise you of potential side effects before you start your treatment.

In very few cases people may experience jaundice, which is the yellowing of skin or eyes. If this happens, stop taking your medicine and tell your doctor straight away. You should always discuss any side effects with your doctor or nurse. It may be possible to change your medication. You could become seriously ill, develop drug-resistant TB or pass TB on to others. This is known as active TB. Latent TB could develop into an active TB disease at a later date, particularly if your immune system becomes weakened.

With treatment, TB can almost always be cured. A course of antibiotics will usually need to be taken for 6 months. Several different antibiotics are used because some forms of TB are resistant to certain antibiotics. If you're infected with a drug-resistant form of TB, treatment with 6 or more different medications may be needed. If you're diagnosed with pulmonary TB, you'll be contagious for about 2 to 3 weeks into your course of treatment. You will not usually need to be isolated during this time, but it's important to take some basic precautions to stop the infection spreading to your family and friends.

If you're in close contact with someone who has TB, you may have tests to see whether you're also infected. These can include a chest X-ray , blood tests , and a skin test called the Mantoux test. Drug-resistant TB can occur when the drugs used to treat TB are misused or mismanaged. Examples of misuse or mismanagement include. These drugs are used to treat all persons with TB disease. These people are more likely to develop TB disease once they are infected, and also have a higher risk of death once they develop TB.

The most important way to prevent the spread of drug-resistant TB is to take all TB drugs exactly as prescribed by the health care provider. No doses should be missed and treatment should not be stopped early. People receiving treatment for TB disease should tell their health care provider if they are having trouble taking the drugs.

Another way to prevent getting drug-resistant TB is to avoid exposure to known drug-resistant TB patients in closed or crowded places such as hospitals, prisons, or homeless shelters. People who work in hospitals or health-care settings where TB patients are likely to be seen should consult infection control or occupational health experts. Treating and curing drug-resistant TB is complicated. Inappropriate management can have life-threatening results.

Drug-resistant TB should be managed by or in close consultation with an expert in the disease. Specifically, FDA indicated that the risks of adverse effects of fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated urinary tract infections who have other treatment options.

While patients receiving fluoroquinolone antibacterial drugs for tuberculosis TB also have a chance of experiencing the adverse effects noted by FDA, fluoroquinolone antibacterial drugs are absolutely necessary for some patients who have drug-resistant TB disease or drug-resistant latent TB infection or who cannot tolerate first-line TB drugs. For these TB patients, there are no better alternatives, and the benefits of fluoroquinolone antibacterial drugs outweigh the risks because TB is not a minor infection, but potentially fatal or debilitating.

If you are a TB patient receiving fluoroquinolone antibacterial drugs and have questions, please contact your medical provider or local or state TB control program.